Idera Pharmaceuticals is a clinical stage biotechnology company developing a novel approach to the treatment of autoimmune diseases and certain genetically defined forms of B-cell lymphoma. Learn More
News and Events
12.4.13
Listen to Idera Pharmaceuticals’ Presentation at the 25th Annual Piper Jaffray Healthcare Conference
Clinical Trials
Idera is advancing to the clinic in genetically defined forms of B-cell lymphoma: activated B-cell-like diffuse large B-cell lymphoma (ABC-DLBCL) and Waldenström’s macroglobulinemia.
“TLR structure” by The cat, used under GNU Free Documentation License / Cropped and colored background from original.
